Dear friends and colleagues,
Our commitment to provide a stellar, multidisciplinary approach when offering the best uro-oncological care to our patients, remains unchanged. The scientific programme of the upcoming 14th European Multidisciplinary Congress on Urological Cancers (EMUC22) will comprise of contemporary and relevant developments in the prevention, diagnosis and management of genito-urinary (GU) cancers.
Join us from 10 to 13 November 2022 in the historic Hungarian capital Budapest for a myriad of vital updates on major trials, emerging technologies, pioneering techniques, and strategies. These will be presented in dedicated sessions and hands-on trainings, interspersed with lively and insightful deliberations.
We have entered a new era wherein metastatic GU cancers can be associated with achievable cure and long-term survival without disease progression. This is thanks to the close involvement of diverse disciplines and collaboration of the European Society for Medical Oncology (ESMO), the European SocieTy Radiation Oncology (ESTRO) and the European Association of Urology (EAU).
EMUC22 will take place in conjunction with the 10th Meeting on the EAU Section on Urological Imaging (ESUI22), European School of Urology (ESU) courses, EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics (ESUP) and the Young Academic Urologists Meeting (YAU).
We look forward to welcoming you in Budapest!
Prof. Peter Hoskin (ESTRO) Prof. Silke Gillessen (ESMO) Prof. Arnulf Stenzl (EAU)
Steering committee Steering Committee Steering Committee